The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Open accessAbstract
BACKGROUND: In light of the increasing rate of dengue infections throughout the world despite vector-control measures, several dengue vaccine candidates are in development. METHODS: In a phase 3 efficacy trial of a tetravalent dengue vaccine in five Latin American countries where dengue is endemic, we randomly assigned healthy children between the ages of 9 and 16 years in a 2:1 ratio to receive three injections of recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV) or placebo at months 0, 6, and 12 under blinded conditions. The children were then followed for 25 months. The primary outcome was vaccine efficacy against symptomatic, virologically confirmed dengue (VCD), regardless of disease severity or serotype, occurring more than 28 days after the third injection. RESULTS: A total of 20,869 healthy children received either vaccine or placebo. At baseline, 79.4% of an immunogenicity subgroup of 1944 children had seropositive status for one or more dengue serotypes. In the per-protocol population, there were 176 VCD cases (with 11,793 person-years at risk) in the vaccine group and 221 VCD cases (with 5809 person-years at risk) in the control group, for a vaccine efficacy of 60.8% (95% confidence interval [CI], 52.0 to 68.0). In the intention-to-treat population (those who received at least one injection), vaccine efficacy was 64.7% (95% CI, 58.7 to 69.8). Serotype-specific vaccine efficacy was 50.3% for serotype 1, 42.3% for serotype 2, 74.0% for serotype 3, and 77.7% for serotype 4. Among the severe VCD cases, 1 of 12 was in the vaccine group, for an intention-to-treat vaccine efficacy of 95.5%. Vaccine efficacy against hospitalization for dengue was 80.3%. The safety profile for the CYD-TDV vaccine was similar to that for placebo, with no marked difference in rates of adverse events. CONCLUSIONS: The CYD-TDV dengue vaccine was efficacious against VCD and severe VCD and led to fewer hospitalizations for VCD in five Latin American countries where dengue is endemic. (Funded by Sanofi Pasteur; ClinicalTrials.gov number, NCT01374516.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Dengue: a continuing global threat
Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., et al. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2460 · Cited by 2,082
If Nothing Goes Wrong, Is Everything All Right?: Interpreting Zero Numerators
Hanley, J. A. (1983) · JAMA · doi:10.1001/jama.1983.03330370053031 · Cited by 1,043
Capeding, M. R., Tran, N. H., Hadinegoro, S. R. S., Ismail, H. I. H. M., Chotpitayasunondh, T., Chua, M. N., Luong, C. Q., Rusmil, K., Wirawan, D. N., Nallusamy, R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61060-6 · Cited by 973
Self-citationSabchareon, A., Wallace, D., Sirivichayakul, C., Limkittikul, K., Chanthavanich, P., Suvannadabba, S., Jiwariyavej, V., Dulyachai, W., Pengsaa, K., Wartel, T. A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61428-7 · Cited by 818
Self-citationImmunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
Rothman, A. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri3014 · Cited by 770
Statistical Methods in Cancer Research, Vol. II: The Design and Analysis of Cohort Studies.
Machin, D., Breslow, N. E., & Day, N. E. (1990) · Biometrics · doi:10.2307/2532481 · Cited by 634
The Epidemiology of Dengue in the Americas Over the Last Three Decades: A Worrisome Reality
San Martín, J. L., Brathwaite, O., Zambrano, B., Solórzano, J. O., Bouckenooghe, A., Dayan, G. H., & Guzmán, M. G. (2010) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0346 · Cited by 546
Self-citationThe History of Dengue Outbreaks in the Americas
Brathwaite Dick, O., San Martín, J. L., Montoya, R. H., del Diego, J., Zambrano, B., & Dayan, G. H. (2012) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.11-0770 · Cited by 491
Self-citation
Cited by
The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus
Kraemer, M. U., Sinka, M. E., Duda, K. A., Mylne, A. Q., Shearer, F. M., Barker, C. M., Moore, C. G., Carvalho, R. G., Coelho, G. E., Van Bortel, W., et al. (2015) · eLife · doi:10.7554/elife.08347 · Cited by 2,160
The global burden of dengue: an analysis from the Global Burden of Disease Study 2013
Stanaway, J. D., Shepard, D. S., Undurraga, E. A., Halasa, Y. A., Coffeng, L. E., Brady, O. J., Hay, S. I., Bedi, N., Bensenor, I. M., Castañeda-Orjuela, C. A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00026-8 · Cited by 1,124
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
Hadinegoro, S. R., Arredondo-García, J. L., Capeding, M. R., Deseda, C., Chotpitayasunondh, T., Dietze, R., Hj Muhammad Ismail, H. I., Reynales, H., Limkittikul, K., Rivera-Medina, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506223 · Cited by 1,077
Self-citationEffect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
Sridhar, S., Luedtke, A., Langevin, E., Zhu, M., Bonaparte, M., Machabert, T., Savarino, S., Zambrano, B., Moureau, A., Khromava, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800820 · Cited by 783
Self-citationGuzman, M. G., Gubler, D. J., Izquierdo, A., Martinez, E., & Halstead, S. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.55 · Cited by 762
España, G., Hogea, C., Guignard, A., ten Bosch, Q. A., Morrison, A. C., Smith, D. L., Scott, T. W., Schmidt, A., & Perkins, T. A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210041 · Cited by 744
Wilder-Smith, A., Ooi, E.-E., Horstick, O., & Wills, B. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32560-1 · Cited by 692
Epidemic arboviral diseases: priorities for research and public health
Wilder-Smith, A., Gubler, D. J., Weaver, S. C., Monath, T. P., Heymann, D. L., & Scott, T. W. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30518-7 · Cited by 573
Smith, L. B., Kasai, S., & Scott, J. G. (2016) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2016.03.005 · Cited by 405
New insights into the immunopathology and control of dengue virus infection
Screaton, G., Mongkolsapaya, J., Yacoub, S., & Roberts, C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3916 · Cited by 394
Dengue Fever: Causes, Complications, and Vaccine Strategies
Khetarpal, N., & Khanna, I. (2016) · Journal of Immunology Research · doi:10.1155/2016/6803098 · Cited by 363
Harapan, H., Michie, A., Sasmono, R. T., & Imrie, A. (2020) · Viruses · doi:10.3390/v12080829 · Cited by 360
A review of Dengvaxia®: development to deployment
Thomas, S. J., & Yoon, I.-K. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1658503 · Cited by 331
Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control
Diamond, M. S., & Pierson, T. C. (2015) · Cell · doi:10.1016/j.cell.2015.07.005 · Cited by 311
Lai, S., Huang, Z., Zhou, H., Anders, K. L., Perkins, T. A., Yin, W., Li, Y., Mu, D., Chen, Q., Zhang, Z., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0336-1 · Cited by 281
Reconstruction of antibody dynamics and infection histories to evaluate dengue risk
Salje, H., Cummings, D. A. T., Rodriguez-Barraquer, I., Katzelnick, L. C., Lessler, J., Klungthong, C., Thaisomboonsuk, B., Nisalak, A., Weg, A., Ellison, D., et al. (2018) · Nature · doi:10.1038/s41586-018-0157-4 · Cited by 270
Dengue burden in India: recent trends and importance of climatic parameters
Mutheneni, S. R., Morse, A. P., Caminade, C., & Upadhyayula, S. M. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.57 · Cited by 268
Kirkpatrick, B. D., Whitehead, S. S., Pierce, K. K., Tibery, C. M., Grier, P. L., Hynes, N. A., Larsson, C. J., Sabundayo, B. P., Talaat, K. R., Janiak, A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1517 · Cited by 262
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
Rey, F. A., Stiasny, K., Vaney, M., Dellarole, M., & Heinz, F. X. (2018) · EMBO reports · doi:10.15252/embr.201745302 · Cited by 259
Dengue infection in India: A systematic review and meta-analysis
Ganeshkumar, P., Murhekar, M. V., Poornima, V., Saravanakumar, V., Sukumaran, K., Anandaselvasankar, A., John, D., & Mehendale, S. M. (2018) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006618 · Cited by 258
History, epidemiology and diagnostics of dengue in the American and Brazilian contexts: a review
Salles, T. S., da Encarnação Sá-Guimarães, T., de Alvarenga, E. S. L., Guimarães-Ribeiro, V., de Meneses, M. D. F., de Castro-Salles, P. F., dos Santos, C. R., do Amaral Melo, A. C., Soares, M. R., Ferreira, D. F., et al. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2830-8 · Cited by 256
Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice
Zhang, M., Sun, J., Li, M., & Jin, X. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.07.013 · Cited by 90
Bowman, N. M., Akialis, K., Cave, G., Barrera, R., Apperson, C. S., & Meshnick, S. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196410 · Cited by 72
Dengue in India: Towards a better understanding of priorities and progress
Shet, A., & Kang, G. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.03.008 · Cited by 21
Metadata
- Authors
- Villar, L., Dayan, G. H., Arredondo-García, J. L., Rivera, D. M., Cunha, R., Deseda, C., Reynales, H., Costa, M. S., Morales-Ramírez, J. O., Carrasquilla, G., Rey, L. C., Dietze, R., Luz, K., Rivas, E., Miranda Montoya, M. C., Cortés Supelano, M., Zambrano, B., Langevin, E., Boaz, M., Tornieporth, N., Saville, M., & Noriega, F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-01-08
- Volume
- 372
- Issue
- 2
- Pages
- 113-123
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2164079841
- Cited by
- 942
- References
- 23
- FWCI
- 122.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.